Table of Contents Understanding MASLD and MASH in Clinical Practice Mechanisms Behind GLP1s and Liver Health Clinical Evidence Supporting GLP1 MASLD MASH Treatment Choosing the Right GLP1 Agent Monitoring and Managing Patients on GLP1s Future Directions in Therapy FAQs Understanding MASLD and MASH in Clinical Practice MASLD, previously labeled as nonalcoholic fatty liver disease (NAFLD), is now identified by the presence of liver steatosis in individuals with metabolic dysfunction, excluding significant alcohol consumption
Tips for Your First Dose Prepare your environment before you take your first injection
They still work somewhat even after long-term use
Glucagon-like peptide receptor agonists (GLP-1 RAs or GLP-1 agonists for short) are drugs manufactured to bind to GLP-1 receptors, essentially mimicking and magnifying the effects of these hormones
As well as helping to lower blood sugar levels, GLP-1 Agonists have important anti-inflammatory effects, can help protect the lungs and have a positive effect on the bacteria in the gut
For extra support with your GLP-1 treatment, you might want to check out TrimRX